Hepatitis Monthly

Published by: Kowsar

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort

Piero Luigi Almasio 1 , * , Anna Licata 1 , Marcello Maida 1 , Fabio Salvatore Macaluso 1 , Andrea Costantino 1 , Nicola Alessi 1 , Stefania Grimaudo 1 , Giulia Accardi 2 , Calogero Caruso 2 and Antonio Craxi 1
Authors Information
1 Sezione di Gastroenterologia ed Epatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy
2 Dipartimento di Biopatologia e Biotecnologie Mediche, University of Palermo, Palermo, Italy
Article information
  • Hepatitis Monthly: November 01, 2016, 16 (11); e31681
  • Published Online: October 16, 2016
  • Article Type: Research Article
  • Received: July 20, 2015
  • Revised: November 28, 2015
  • Accepted: December 19, 2015
  • DOI: 10.5812/hepatmon.31681

To Cite: Almasio P L, Licata A, Maida M, Macaluso F S, Costantino A, et al. Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort, Hepat Mon. 2016 ; 16(11):e31681. doi: 10.5812/hepatmon.31681.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010; 52(5): 745-58[DOI][PubMed]
  • 2. Kim WR, Lindor KD, Locke G3, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000; 119(6): 1631-6[PubMed]
  • 3. Prince MI, James OF. The epidemiology of primary biliary cirrhosis. Clin Liver Dis. 2003; 7(4): 795-819[PubMed]
  • 4. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology. 2004; 127(2): 485-92[PubMed]
  • 5. Zhang L, Weetman AP, Bassendine M, Oliveira DB. Major histocompatibility complex class-II alleles in primary biliary cirrhosis. Scand J Immunol. 1994; 39(1): 104-6[PubMed]
  • 6. Invernizzi P, Battezzati PM, Crosignani A, Perego F, Poli F, Morabito A, et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol. 2003; 38(4): 401-6[PubMed]
  • 7. Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology. 2008; 48(6): 1906-12[DOI][PubMed]
  • 8. Liu X, Invernizzi P, Lu Y, Kosoy R, Lu Y, Bianchi I, et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet. 2010; 42(8): 658-60[DOI][PubMed]
  • 9. Juran BD, Lazaridis KN. Genetics and genomics of primary biliary cirrhosis. Clin Liver Dis. 2008; 12(2): 349-65[DOI][PubMed]
  • 10. Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, Shin SY, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet. 2011; 43(4): 329-32[DOI][PubMed]
  • 11. Poupon R, Ping C, Chretien Y, Corpechot C, Chazouilleres O, Simon T, et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol. 2008; 49(6): 1038-45[DOI][PubMed]
  • 12. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009; 360(24): 2544-55[DOI][PubMed]
  • 13. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005; 42(5): 1194-202[DOI][PubMed]
  • 14. Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology. 2006; 43(3): 525-31[DOI][PubMed]
  • 15. Leung PS, Park O, Tsuneyama K, Kurth MJ, Lam KS, Ansari AA, et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol. 2007; 179(4): 2651-7[PubMed]
  • 16. Selmi C, Gershwin ME. The role of environmental factors in primary biliary cirrhosis. Trends Immunol. 2009; 30(8): 415-20[DOI][PubMed]
  • 17. Metcalf JV, Bhopal RS, Gray J, Howel D, James OF. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 1997; 26(4): 830-6[PubMed]
  • 18. James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology. 1999; 30(2): 390-4[DOI][PubMed]
  • 19. Delgado J, Sperber AD, Novack V, Delgado B, Edelman L, Gaspar N, et al. The epidemiology of primary biliary cirrhosis in southern Israel. Isr Med Assoc J. 2005; 7(11): 717-21[PubMed]
  • 20. Pla X, Vergara M, Gil M, Dalmau B, Cistero B, Bella RM, et al. Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Eur J Gastroenterol Hepatol. 2007; 19(10): 859-64[DOI][PubMed]
  • 21. Myers RP, Shaheen AA, Fong A, Burak KW, Wan A, Swain MG, et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology. 2009; 50(6): 1884-92[DOI][PubMed]
  • 22. Piazza A, Olivetti E, Griffo RM, Rendine S, Amoroso A, Barbanti M, et al. The distribution of HLA antigens in Italy. Gene Geogr. 1989; 3(2-3): 141-64[PubMed]
  • 23. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461(7262): 399-401[DOI][PubMed]
  • 24. Petta S, Grimaudo S, Camma C, Cabibi D, Di Marco V, Licata G, et al. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. J Hepatol. 2012; 56(6): 1356-62[DOI][PubMed]
  • 25. Kempuraj D, Donelan J, Frydas S, Iezzi T, Conti F, Boucher W, et al. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int J Immunopathol Pharmacol. 2004; 17(2): 103-6[PubMed]
  • 26. Morrow MP, Pankhong P, Laddy DJ, Schoenly KA, Yan J, Cisper N, et al. Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood. 2009; 113(23): 5868-77[DOI][PubMed]
  • 27. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, et al. Primary biliary cirrhosis. Hepatology. 2009; 50(1): 291-308[DOI][PubMed]
  • 28. O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G. Alcoholic liver disease. Hepatology. 2010; 51(1): 307-28[DOI][PubMed]
  • 29. de Franchis R, Baveno V. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010; 53(4): 762-8[DOI][PubMed]
  • 30. European Association for the Study of the L. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009; 51(2): 237-67[DOI][PubMed]
  • 31. Muratori P, Granito A, Pappas G, Muratori L, Lenzi M, Bianchi FB. Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. QJM. 2008; 101(6): 505-6[DOI][PubMed]
  • 32. Selmi C, Gershwin ME, Lindor KD, Worman HJ, Gold EB, Watnik M, et al. Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology. 2007; 46(6): 1836-43[DOI][PubMed]
  • 33. Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology. 2006; 44(1): 91-8[DOI][PubMed]
  • 34. Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut. 2004; 53(6): 865-70[PubMed]
  • 35. Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology. 1990; 98(6): 1567-71[PubMed]
  • 36. Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol. 1994; 20(6): 707-13[PubMed]
  • 37. Liu B, Zhang FC, Zhang ZL, Zhang W, Gao LX. Interstitial lung disease and Sjogren's syndrome in primary biliary cirrhosis: a causal or casual association? Clin Rheumatol. 2008; 27(10): 1299-306[DOI][PubMed]
  • 38. Hatzis GS, Fragoulis GE, Karatzaferis A, Delladetsima I, Barbatis C, Moutsopoulos HM. Prevalence and longterm course of primary biliary cirrhosis in primary Sjogren's syndrome. J Rheumatol. 2008; 35(10): 2012-6[PubMed]
  • 39. Sorokin A, Brown JL, Thompson PD. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis. 2007; 194(2): 293-9[DOI][PubMed]
  • 40. Cash WJ, McCance DR, Young IS, McEneny J, Cadden IS, McDougall NI, et al. Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk. Hepatol Res. 2010; 40(11): 1098-106[DOI][PubMed]
  • 41. Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, et al. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology. 2010; 139(1): 120-9 e18[DOI][PubMed]
  • 42. Bochud PY, Bibert S, Kutalik Z, Patin E, Guergnon J, Nalpas B, et al. IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology. 2012; 55(2): 384-94[DOI][PubMed]
  • 43. Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, et al. Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun. 2015; 6: 6422[DOI][PubMed]
  • 44. Petta S, Ferraro D, Camma C, Cabibi D, Di Cristina A, Di Marco V, et al. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther. 2012; 17(5): 823-31[DOI][PubMed]
  • 45. Di Marco V, Bronte F, Calvaruso V, Capra M, Borsellino Z, Maggio A, et al. IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica. 2012; 97(5): 679-86[DOI][PubMed]
  • 46. Cieslar-Pobuda A, Wiechec E. Research on liver regeneration as an answer to the shortage of donors for liver transplantation. Hepatol Res. 2014; 44(9): 944-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments